Receive The Newest Study Notifications

It is more important than ever to take care of one another and be diligent and wise in our daily activities. This press release was orginally distributed by SBWire Santa Ana, CA -- (SBWIRE) -- 03/24/2020 -- Per the FDA Guideline on Conduct of Clinical Trials of...

ClinOne, an industry leader in remote clinical trial patient management, added the CU Healthcare Innovation Fund as the lead investor for their Series-A financing, with a first closing of $3.6 million. The fund is affiliated with the Anschutz Medical Campus in Denver...

European site enrollment concerns grow to 85% Over the course of just one week, US clinical research study sites’ concern about COVID-19-related interruptions to recruitment and retention has increased by 124%, jumping from 25% to 56% according to an ongoing...

Trial also achieves statistical significance in key secondary endpoints Novavax to submit a U.S. BLA under FDA’s accelerated approval pathway Company to host investor conference call today at 8:30 a.m. EDT GAITHERSBURG, Md., March 24, 2020 (GLOBE NEWSWIRE) -- Novavax,...

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced an update to the Press Release of January 24, 2020. We have now completed the sterilization, quality assurance,...

EDMONTON, March 24, 2020 /PRNewswire/ - OncoQuest Inc. ("OncoQuest" or the "Company"), a privately held, cancer immunotherapy company today announced the publication of two reports relating to the recently completed Phase 2 trial conducted in the US...

ANN ARBOR, Mich., March 23, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that two pooled analyses from four Phase 3 clinical trials of NEXLETOL and results from the Phase 2 (1002-058) study of NEXLIZET will be presented at the American College of...

Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that following a successful clinical evaluation of its Logix Smart™ COVID-19 Test, the Company will begin...

RALEIGH, N.C., March 20, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences announced today the commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tiered initiative that allows employers, payers, providers and health systems to track the health...

SOUTH SAN FRANCISCO, Calif., March 23, 2020 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of serious fibrotic diseases, today announced that it has dosed...

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first planned commercial product is designed to use rapid pulses of designed acoustic shockwaves in conjunction with existing lasers to...

Genentech is launching a phase 3 clinical trial evaluating tocilizumab (Actemra) plus standard of care for use in hospitalized adult patients with severe COVID-19 pneumonia, according to a company press release. Tocilizumab, a humanized interleukin-6 (IL-6) receptor...

Study to Tackle Leading Cause of Death in COVID-19 Patients Lenzilumab is a monoclonal antibody that neutralizes GM-CSF, a cytokine up-regulated in COVID-19 patients that can cause a harmful immune response Clinical evidence suggests that this response contributes to...

Conference call on Monday, March 30, 2020, at 5:00 p.m. ET featuring study investigator Debra L. Richardson, MD CAMBRIDGE, Mass., March 20, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (MRSN), a clinical-stage biopharmaceutical company focused on discovering...

HANGZHOU, China, March 23, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets, today announced that its new drug candidate taletrectinib has received IND clearance...

  Randomizations concluded and trial participation in process of concluding to ensure patient safety during COVID-19 pandemic AXS-05 and placebo arms fully enrolled with estimated completion rate of more than 90% Topline results now expected early 2Q 2020 NEW...

VANCOUVER, British Columbia, March 20, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce today that it has chosen...

The Feinstein Institutes for Medical Research, the research arm of Northwell Health, announced today the enrollment of three clinical trials in the ongoing effort to combat COVID-19, the novel coronavirus. Feinstein Institutes researchers are teaming up with Gilead...

WARREN, N.J., March 20, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted emergency expanded access...

Hydroxychloroquine and a related drug, chloroquine, are currently under evaluation in clinical trials for the treatment of COVID-19. Novartis Sandoz division will pursue appropriate regulatory authorizations and, upon approval, will work with stakeholders to determine...